Last reviewed · How we verify
NCT05760768
The Effect of Individualized Exercise Guidance on Pregnancy Outcome
NA trial testing Individualized exercise guidance in Pregnancy Outcome in 326 participants. Completed in 30 September 2022.
31 January 2022
Quick facts
| Lead sponsor | Peking Union Medical College Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 326 |
| Start date | 1 December 2021 |
| Primary completion | 31 January 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Individualized exercise guidance
Conditions studied
- Pregnancy Outcome — all drugs for Pregnancy Outcome →
- Gestational Weight Gain — all drugs for Gestational Weight Gain →
- Mediation — all drugs for Mediation →
- Macrosomia, Fetal — all drugs for Macrosomia, Fetal →
Sponsor
Peking Union Medical College Hospital
Who can join
Adults 20 to 45, female only, with Pregnancy Outcome or Gestational Weight Gain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A single center, randomized controlled trial was conducted to investigate whether individualized exercise guidance was more effective in improving pregnancy outcomes in normal pregnant women. What's more, the trial was also conducted to find out whether there is a mediating effect between prenatal exercise and pregnancy outcomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mediating effect of gestational weight gain on the preventive effect of exercise during pregnancy on macrosomia: a randomized clinical trial.
Yang X, Wang G, Liu N, Wang Y, et al · · 2024 · cited 1× · PMID 38778289 · DOI 10.1186/s12884-024-06527-7
Verify or expand the search:
- PubMed search for NCT05760768
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pregnancy Outcome
Currently open trials in the same condition.
- NCT06705712 — Physical Activity, Fertility, and Spontaneous Abortion in Danish Couples Trying to Conceive · NA · recruiting
- NCT05870878 — Generation R Next - Optimaal Opgroeien · NA · recruiting
- NCT05733377 — Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome · recruiting
- NCT03215368 — The Ma'Anshan Birth Cohort (MABC) · active not recruiting
- NCT04529889 — GDM and Its Consequences in Mothers and Offsprings · recruiting
Other Peking Union Medical College Hospital trials
Trials by the same sponsor.
- NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
- NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
- NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
- NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
- NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05760768 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
- Last refreshed: 8 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05760768.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing